Swiss contract development and manufacturing organization ten23health has achieved B Corp certification, recognizing its commitment to social and environmental responsibility in the pharmaceutical industry.
ten23health Becomes First Sterile Product CDMO to Earn B Corp Certification Read More »
Since its launch in 2006, Valais-based Lugaia has gone from strength to strength. It has now established itself as a major player in the global market for containment solutions. Company owner Viktor Schnyder explains what makes Lugaia tick and how the company benefits from its location in the Valais. Lugaia has a history stretching back
Valaisan SME Lugaia rides the wave of success with its niche products Read More »
We’re thrilled to announce that CEIDOS, a start-up, based at our BioArk Monthey technology site, has just been endorsed by the Innosuisse Innovation Council, securing significant funding! With a total budget of 1.2 million francs, their C-Netics technology will be enhanced in partnership with CSEM and HES-SO Valais-Wallis. This project will perfect their online monitoring
CEIDOS secures support from Innosuisse in partnership with CSEM & HES-SO Valais-Wallis Read More »
Support innovation in Switzerland by voting for these promising life sciences startups from the Valais region. A strong contingent of 27 startups from the Swiss canton of Valais are competing in the prestigious TOP 100 Swiss Startup Award 2024, showcasing the region’s thriving life sciences ecosystem. Many of these startups, including CEIDOS, GaDia, Orio Therapeutics,
Valais Startups Shine in the TOP 100 Swiss Startup Award 2024 Read More »
EPFL expands its “Les sciences, ça m’intéresse!” program to Valais, offering engaging science activities for children aged 7 to 16.
Inspiring Young Minds in Valais: EPFL’s Science Outreach Program Read More »
The young company Curio Biotech uses human tissue to test cosmetic products and medicines. Thanks to its innovative working method, the company is helping to reduce the number of animal experiments. The company’s founder, Chennakesava Cuddapah, sees great potential in Curio Biotech’s field of activity. In this interview, he gives us a look behind the
Curio Biotech : A start-up in Visp makes animal testing redundant Read More »
Swiss CleanTech startup DePoly, supported by The Ark Foundation, has begun construction of its groundbreaking Showcase Plant in Monthey, marking a significant milestone in sustainable plastic recycling and reinforcing the region’s position as a hub for innovative technologies. A Leap Forward in Plastic Recycling DePoly’s new facility, located at the CIMO site in Monthey, will
DePoly Breaks Ground on Its First Revolutionary Plastic Recycling Plant in Monthey Read More »
Discover the interview of Ziad Julier, co-founder of start-up Orio Therapeutics, based at the BioArk in Monthey, on Radio Chablais. Ziad presents their new cardio-protective drug technology, currently in the development phase, and his entrepreneurial journey. > Listen here “Our ultimate goal is for an acute patient who has had a heart attack to be
Orio Therapeutics on Radio Chablais Read More »
Nanobactérie, whose AlphaOnco subsidiary is based at the BioArk in Monthey, announces a strategic partnership with EP Equity Investment (EPEI), a Luxembourg-based investment company.
Anti-cancer treatment: new high-profile investor for Nanobacteria! Read More »
ten23 health (based in Basel and at BioArk Visp) and Ypsomed announced that they are entering into a strategic partnership to advance thecommercialization of the YpsoDose wearable injector for subcutaneous self-injection of large-volume doses.
ten23 health collaborates with Ypsomed to market a new patch injector Read More »
